(Circulation. 2001;103:782.)
© 2001 American Heart Association, Inc.
Editorial |
-Adrenergic Receptor Activation?
From the Cardiomyopathy Program and Cardiovascular Section, Boston University Medical Center, and Boston University School of Medicine, Boston, Mass.
Correspondence to Wilson S. Colucci, MD, Cardiovascular Section, Boston University Medical Center, 88 E. Newton Street, Boston, MA 02118. E-mail wilson.colucci@bmc.org
Key Words: Editorials antioxidants contractility receptors, adrenergic, beta myocardium
Oxidant
byproducts, such as superoxide anion
(O2) and hydrogen
peroxide, are produced as a consequence of normal aerobic metabolism.
These molecules, which are highly reactive with other biological
molecules, are referred to as reactive oxygen species (ROS). Under
normal physiological conditions, ROS production is balanced by an
efficient system of antioxidants, molecules that are capable of
scavenging ROS and thereby preventing oxidant damage. At the cellular
level, naturally occurring enzymatic antioxidants such as superoxide
dismutase, glutathione peroxidase, and catalase play an important role
in the conversion of ROS to oxygen and water. Several nonenzymatic
antioxidants, including the lipid-soluble antioxidants vitamin E and
-carotene and the water-soluble antioxidants vitamin C and
glutathione, are also important in scavenging free radicals. Vitamin C
in particular protects plasma lipids from peroxidation, scavenges
O2, and plays a
role in recycling vitamin E.
In pathological states, ROS may be present in relative
excess. This shift of the balance in favor of oxidation, termed
"oxidative stress," may have detrimental effects on cellular and
tissue function. Oxidative stress is thought to contribute to the
pathogenesis of a wide variety of disease states, including
atherosclerosis1 and cancer,
as well as to the normal process of aging. There is increasing evidence
that myocardial oxidative stress may contribute to disease progression
in heart failure.2 Although
the effects of oxidative stress on the myocardium have been
investigated in pathological states, very little is known about the
role of ROS in the regulation of normal cardiac function. Recently,
Ekelund et al3
This article has been cited by other articles:
![]() |
S. Srivastava, B. Chandrasekar, Y. Gu, J. Luo, T. Hamid, B. G. Hill, and S. D. Prabhu Downregulation of CuZn-superoxide dismutase contributes to {beta}-adrenergic receptor-mediated oxidative stress in the heart Cardiovasc Res, June 1, 2007; 74(3): 445 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pop-Busui, I. Kirkwood, H. Schmid, V. Marinescu, J. Schroeder, D. Larkin, E. Yamada, D. M. Raffel, and M. J. Stevens Sympathetic dysfunction in type 1 diabetes: Association with impaired myocardial blood flow reserve and diastolic dysfunction J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2368 - 2374. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |